Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Int J Clin Oncol. 2011 Oct;16(5):464-72. doi: 10.1007/s10147-011-0307-2. Epub 2011 Aug 17.
Colorectal cancer is the second most common cancer, and is the third leading cause of cancer-related death in Japan. The majority of these deaths is attributable to liver metastasis. Recent studies have provided increasing evidence that the chemokine-chemokine receptor system is a potential mechanism of tumor metastasis via multiple complementary actions: (a) by promoting cancer cell migration, invasion, survival and angiogenesis; and (b) by recruiting distal stromal cells (i.e., myeloid bone marrow-derived cells) to indirectly facilitate tumor invasion and metastasis. Here, we discuss recent preclinical and clinical data supporting the view that chemokine pathways are potential therapeutic targets for liver metastasis of colorectal cancer.
结直肠癌是第二大常见癌症,也是日本癌症相关死亡的第三大主要原因。这些死亡病例大多数归因于肝转移。最近的研究提供了越来越多的证据表明,趋化因子-趋化因子受体系统是肿瘤转移的一个潜在机制,通过多种互补作用:(a) 促进癌细胞迁移、侵袭、存活和血管生成;和 (b) 通过募集远处的基质细胞(即骨髓源性细胞)来间接促进肿瘤的侵袭和转移。在这里,我们讨论了支持趋化因子途径是结直肠癌肝转移潜在治疗靶点的最新临床前和临床数据。